Gara Jalqabaatti › Kansara Harkaa (Karsinomaa Seli Renal) › North Carolina › Durham
Qorannoo klinikaalii Kansara Harkaa (Karsinomaa Seli Renal) Durham, NC keessatti
Qorannoo 12 Kansara Harkaa (Karsinomaa Seli Renal) f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke Cancer Institute ( Site 5015), Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #12, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, Durham
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC- Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
- Duke Cancer Center Southpoint, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 1
- Xencor Investigative Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Center /ID# 251975, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Namoota walitti qabaa jiraSadarkaa 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Qorannoo Kansara Harkaa (Karsinomaa Seli Renal) magaalota biroo keessatti
- Houston, TXQorannoo 35
- New York City, NYQorannoo 27
- Nashville, TNQorannoo 23
- Dallas, TXQorannoo 23
- St. Louis, MOQorannoo 23
- Los Angeles, CAQorannoo 20
- Boston, MAQorannoo 16
- Baldwin Park, CAQorannoo 16
- Philadelphia, PAQorannoo 15
- Pittsburgh, PAQorannoo 15
- Queens, NYQorannoo 15
- Rochester, MNQorannoo 14
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 64
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 33
- Kansara MetastatikiiQorannoo 33
- Kansarii ProstateQorannoo 32
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.